Novavax down 20% as FDA Documents on Covid Vaccine Express Myocarditis Concerns

seekingalpha2022-06-03

Shares of Novavax (NASDAQ: NVAX) are down more than 20% today after U.S. FDA briefing documents on its COVID-19 vaccine expressed concern over four cases of myocarditis -- a rare heart inflammation --...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

TF105
2022-06-04
TF105
Oh well...
FattyBull
2022-06-04
FattyBull
Nice
jannn
2022-06-04
jannn
[smile]
ccwee
2022-06-04
ccwee
read
Wtt
2022-06-04
Wtt
Like
Kiki19
2022-06-04
Kiki19
Please like

Leave a comment

512

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1166761206?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-06-03 23:07","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"1166761206","market":"us","top_or_hot":-1,"title":"Novavax down 20% as FDA Documents on Covid Vaccine Express Myocarditis Concerns","media":"seekingalpha","content":"<div>\n<p>Shares of Novavax (NASDAQ: NVAX) are down more than 20% today after U.S. FDA briefing documents on its COVID-19 vaccine expressed concern over four cases of myocarditis -- a rare heart inflammation --...</p>\n\n<a href=\"https://seekingalpha.com/news/3845495-novavax-down-17-fda-briefing-documents-covid-vaccine-myocarditis-concerns\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax down 20% as FDA Documents on Covid Vaccine Express Myocarditis Concerns</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax down 20% as FDA Documents on Covid Vaccine Express Myocarditis Concerns\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-06-03 23:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3845495-novavax-down-17-fda-briefing-documents-covid-vaccine-myocarditis-concerns><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Novavax (NASDAQ: NVAX) are down more than 20% today after U.S. FDA briefing documents on its COVID-19 vaccine expressed concern over four cases of myocarditis -- a rare heart inflammation --...</p>\n\n<a href=\"https://seekingalpha.com/news/3845495-novavax-down-17-fda-briefing-documents-covid-vaccine-myocarditis-concerns\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NVAX","symbol_name":"诺瓦瓦克斯医药","start_time":0,"source_url":"https://seekingalpha.com/news/3845495-novavax-down-17-fda-briefing-documents-covid-vaccine-myocarditis-concerns","article_id":"1166761206","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1166761206","pubTimestamp":1654268850,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Shares of Novavax (NASDAQ: NVAX) are down more than 20% today after U.S. FDA briefing documents on i","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"translate_title":"Novavax下跌20%，因为美国食品和药物管理局关于Covid疫苗的文件表达了心肌炎的担忧","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVAX":0.9},"content_text":"Shares of Novavax (NASDAQ: NVAX) are down more than 20% today after U.S. FDA briefing documents on its COVID-19 vaccine expressed concern over four cases of myocarditis -- a rare heart inflammation -- after administration of the shot in pivotal trials.There was one cases of myocarditis observed 20 days post vaccination in the placebo arm of the pivotal studies, though the FDA said that it was unrelated to the placebo vaccination. Two cases of pericarditis were also associated in the treatment arm. The FDA said the results \"raise a concern for a causal association\" between the vaccine, NVX-CoV2373, and myocarditis.\"Data from passive surveillance during post-authorization use in other countries also indicate a higher than expected rate of myocarditis and pericarditis (mainly pericarditis) associated with the vaccine,\" according to U.S. FDA briefing documents ahead of an advisory committee meeting.The FDA said five of the six myocarditis/pericarditis events were reported within two weeks of administration and four of them occurred in young men.mRNA vaccines from Pfizer (PFE)/BioNTech (BNTX) and Moderna (MRNA) were also associated with rare cases of myocarditis -- also particularly in young men -- leading to warnings added to fact sheets for those vaccines.Overall efficacy for NVX-CoV2373 was 90.4%. However, data showed that the efficacy in the those 65 years and older was only 78.6%.The agency's Vaccines and Related Biological Products Advisory Committee will meet on June 7 to discuss Novavax's (NVAX) Emergency Use Authorization request for NVX-CoV2373.The documents note that enrollment and follow-up for the studies occurred prior to the Delta and Omicron variants becoming the dominant strains, so data on against those variants is unavailable.\"However, based on the efficacy estimate in the clinical trial of this vaccine, it is more likely than not that the vaccine will provide some meaningful level of protection against COVID-19 due to Omicron, in particular against more severe disease,\" the documents state.FDA reviewers also noted that because Novavax analyses have relatively short follow-up, they were unable to determine efficacy past two months.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9059193032,"gmtCreate":1654308264126,"gmtModify":1676535429227,"author":{"id":"4103845292937490","authorId":"4103845292937490","name":"TF105","avatar":"https://community-static.tradeup.com/news/970ff314f46a910a166b2a93d12f115a","vip":1,"hat":"https://static.tigerbbs.com/a3dee1aa3a3a3c1814833a4d3f8a5669","crmLevel":2,"crmLevelSwitch":0,"idStr":"4103845292937490","authorIdStr":"4103845292937490"},"htmlText":"Oh well...&nbsp;","listText":"Oh well...&nbsp;","text":"Oh well...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9059193032","repostId":1166761206,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9059190330,"gmtCreate":1654308153820,"gmtModify":1676535429055,"author":{"id":"4115527649974162","authorId":"4115527649974162","name":"FattyBull","avatar":"https://community-static.tradeup.com/news/373415101d06ff7417c1853d1330e794","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":5,"crmLevelSwitch":0,"idStr":"4115527649974162","authorIdStr":"4115527649974162"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9059190330","repostId":1166761206,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9059341407,"gmtCreate":1654306374409,"gmtModify":1676535428480,"author":{"id":"3580090055250591","authorId":"3580090055250591","name":"jannn","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3580090055250591","authorIdStr":"3580090055250591"},"htmlText":"[smile]&nbsp;","listText":"[smile]&nbsp;","text":"[smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9059341407","repostId":1166761206,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9059362788,"gmtCreate":1654304762444,"gmtModify":1676535427721,"author":{"id":"3581829959470650","authorId":"3581829959470650","name":"ccwee","avatar":"https://static.tigerbbs.com/652d99331e3c23c682d7e58cfc9f6544","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3581829959470650","authorIdStr":"3581829959470650"},"htmlText":"read","listText":"read","text":"read","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9059362788","repostId":1166761206,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9059394729,"gmtCreate":1654301533961,"gmtModify":1676535426758,"author":{"id":"3569796947257349","authorId":"3569796947257349","name":"Wtt","avatar":"https://static.tigerbbs.com/7406dcbfb02a072a2aa86f3c4d10c168","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3569796947257349","authorIdStr":"3569796947257349"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9059394729","repostId":1166761206,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9059394661,"gmtCreate":1654301508253,"gmtModify":1676535426747,"author":{"id":"4097387260130260","authorId":"4097387260130260","name":"Kiki19","avatar":"https://static.itradeup.com/news/1330ce44324f235bf8d1fd1b32e7b559","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"4097387260130260","authorIdStr":"4097387260130260"},"htmlText":"Please like&nbsp;","listText":"Please like&nbsp;","text":"Please like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9059394661","repostId":1166761206,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":512,"commentSize":46,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1166761206"}